Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

Prevention Matters: A Long-Term Strategy to Stop Substance Use and Save Lives

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. The opioid epidemic was recently declared a national public health emergency – and for good reason.  In Indiana, an adult is now more likely to die from a drug overdose than a motor vehicle accident. But opioids aren’t the only substances fueling […]

Proven School-Based Prevention Programs: One Key to Tackling Addiction to Opioids & Other Drugs

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. Substance use is a significant problem in Indianapolis and across the state, and it often begins early. Intervening during school-age years, even as early as elementary school, has the potential to prevent substance use and put children on a path […]